The consistency of our docking results with previously reported experimental data further substantiates the potential of quercetin as a promising natural inhibitor of ACE2, with implications for therapeutic applications against cardiovascular diseases and viral infections. This evidence concerns the gene ACE2 and cardiovascular disorder.